{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T12:41:55Z","timestamp":1791636115225,"version":"4.3.4"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVES:<\/jats:title>\n                    <jats:p>To determine the impact of short-acting beta-blocker therapy on outcomes in adult patients with septic shock.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SOURCES:<\/jats:title>\n                    <jats:p>We searched MEDLINE, Embase, and unpublished sources from inception to April 19, 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY SELECTION:<\/jats:title>\n                    <jats:p>We included randomized controlled trials (RCTs) that evaluated short-acting beta-blockers compared with usual care in patients with septic shock.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA EXTRACTION:<\/jats:title>\n                    <jats:p>We collected data regarding study and patient characteristics, beta-blocker administration, and clinical, hemodynamic, and biomarker outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SYNTHESIS:<\/jats:title>\n                    <jats:p>\n                      Twelve RCTs proved eligible (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 1170 patients). Short-acting beta-blockers may reduce 28-day mortality (relative risk [RR], 0.76; 95% CI, 0.62\u20130.93; low certainty) and probably reduce new-onset tachyarrhythmias (RR, 0.37; 95% CI, 0.18\u20130.78; moderate certainty) but may increase the duration of vasopressors (mean difference [MD], 1.04 d; 95% CI, 0.37\u20131.72; low certainty). Furthermore, there is an uncertain effect as to whether short-acting beta blockers impact 90-day mortality (RR, 0.98; 95% CI, 0.73\u20131.31), ICU length of stay (MD, \u20130.75 d; 95% CI, \u20133.43 to 1.93 d), hospital length of stay (MD, 1.03 d; 95% CI, \u20131.92 to 3.98 d), duration of mechanical ventilation (MD, \u20130.10 d; 95% CI, \u20131.25 to 1.05 d) (all very low certainty), bradycardia episodes (RR, 3.14; 95% CI, 0.91\u201314.01), and hypotension episodes (RR, 4.74; 95% CI, 1.62\u201314.01) (all very low certainty).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>In patients with septic shock, short-acting beta-blockers may improve survival and reduce new-onset tachyarrhythmias. However, these findings were based on low certainty evidence and given ongoing concerns regarding adverse effects and the increase duration of vasopressor use, we need larger and more rigorous RCTs to evaluate this intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000006604","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T11:02:35Z","timestamp":1740567755000},"page":"e1125-e1139","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Impact of Short-Acting Beta-Blockers on the Outcomes of Patients With Septic Shock: A Systematic Review and Meta-Analysis"],"prefix":"10.1097","volume":"53","author":[{"given":"Chris","family":"McChesney","sequence":"first","affiliation":[{"name":"Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Orozco","sequence":"additional","affiliation":[{"name":"Centro de Investigaciones Cl\u00ednicas, Fundaci\u00f3n Valle del Lili, Cali, Colombia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Fiorini","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Department of Medicine, Schulich School of Medicine, Windsor, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle Yee Suet","family":"Wong","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marat","family":"Slessarev","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Prager","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Kao","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Leligdowicz","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada."},{"name":"Robarts Research Institute, Western University, London, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Sharif","sequence":"additional","affiliation":[{"name":"Division of Emergency Medicine, Department of Medicine, McMaster University, Hamilton, ON, Canada."},{"name":"Division of Critical Care, Department of Medicine, McMaster University, Hamilton, ON, Canada."},{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley","family":"Lewis","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Department of Medicine, McMaster University, Hamilton, ON, Canada."},{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Rochwerg","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Department of Medicine, McMaster University, Hamilton, ON, Canada."},{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimia","family":"Honarmand","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Department of Medicine, Mackenzie Health, Vaughan, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Ball","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Arntfield","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Houlton","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan","family":"VanNynatten","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Basmaji","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"R1-20250506","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1177\/0885066618784861","article-title":"Fluid management in sepsis.","volume":"34","author":"Brown","year":"2019","journal-title":"J Intensive Care Med"},{"key":"R2-20250506","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJMoa1500896","article-title":"Trial of early, goal-directed resuscitation for septic shock.","volume":"372","author":"Mouncey","year":"2015","journal-title":"N Engl J Med"},{"key":"R3-20250506","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa010307","article-title":"Early goal-directed therapy in the treatment of severe sepsis and septic shock.","volume":"345","author":"Rivers","year":"2001","journal-title":"N Engl J Med"},{"key":"R4-20250506","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.21037\/jtd.2019.12.51","article-title":"Sepsis trends: Increasing incidence and decreasing mortality, or changing denominator?","volume":"12","author":"Rhee","year":"2020","journal-title":"J Thorac Dis"},{"key":"R5-20250506","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/cc8026","article-title":"Bench-to-bedside review: \u03b2-adrenergic modulation in sepsis.","volume":"13","author":"de Montmollin","year":"2009","journal-title":"Crit Care"},{"key":"R6-20250506","doi-asserted-by":"crossref","first-page":"E1041","DOI":"10.21037\/jtd.2016.08.52","article-title":"Beta-blockers in patients with septic shock: Plenty of promise, but no hard evidence yet.","volume":"8","author":"Kim","year":"2016","journal-title":"J Thorac Dis"},{"key":"R7-20250506","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s10557-021-07248-1","article-title":"The combination of beta-blockers and ACE inhibitors across the spectrum of cardiovascular diseases.","volume":"37","author":"Strauss","year":"2023","journal-title":"Cardiovasc Drugs Ther"},{"key":"R8-20250506","first-page":"759","article-title":"Esmolol improves clinical outcome and tissue oxygen metabolism in patients with septic shock through controlling heart rate.","volume":"27","author":"Xinqiang","year":"2015","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"R9-20250506","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jama.2013.278477","article-title":"Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: A randomized clinical trial.","volume":"310","author":"Morelli","year":"2013","journal-title":"JAMA"},{"key":"R10-20250506","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s40261-015-0325-3","article-title":"Combination therapy with milrinone and esmolol for heart protection in patients with severe sepsis: A prospective, randomized trial.","volume":"35","author":"Wang","year":"2015","journal-title":"Clin Drug Investig"},{"key":"R11-20250506","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s42077-020-00107-5","article-title":"Evaluation of the safety and efficacy of beta blockers in septic patients: A randomized control trial.","volume":"12","author":"Gadallah","year":"2020","journal-title":"Ain-Shams J Anesthesiol"},{"key":"R12-20250506","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/SHK.0000000000001905","article-title":"Esmolol to treat the hemodynamic effects of septic shock: A randomized controlled trial.","volume":"57","author":"Cocchi","year":"2022","journal-title":"Shock"},{"key":"R13-20250506","first-page":"390","article-title":"Effect of esmolol on hemodynamics and clinical outcomes in patients with septic shock.","volume":"29","author":"Wang","year":"2017","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"R14-20250506","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12871-023-01983-8","article-title":"Evaluating the effects of esmolol on cardiac function in patients with septic cardiomyopathy by speck-tracking echocardiography\u2014a randomized controlled trial.","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Anesthesiol"},{"key":"R15-20250506","first-page":"714","article-title":"Effects of the \u03b2-blockers on cardiac protection and hemodynamics in patients with septic shock: A prospective study.","volume":"26","author":"Yang","year":"2014","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"R16-20250506","first-page":"1317","article-title":"Effect of esmolol in septic shock patients with tachycardia: A randomized clinical trial.","volume":"99","author":"Liu","year":"2019","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"R17-20250506","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.chest.2021.01.009","article-title":"Effect of ultrashort-acting \u03b2-blockers on mortality in patients with sepsis with persistent tachycardia despite initial resuscitation: A systematic review and meta-analysis of randomized controlled trials.","volume":"159","author":"Hasegawa","year":"2021","journal-title":"Chest"},{"key":"R18-20250506","doi-asserted-by":"crossref","first-page":"154916","DOI":"10.1016\/j.cyto.2019.154916","article-title":"Prognosis of \u03b2-adrenergic blockade therapy on septic shock and sepsis: A systematic review and meta-analysis of randomized controlled studies.","volume":"126","author":"Ja","year":"2020","journal-title":"Cytokine"},{"key":"R19-20250506","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1185\/03007995.2015.1062357","article-title":"Beta-blocker use in severe sepsis and septic shock: A systematic review.","volume":"31","author":"Sanfilippo","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"R20-20250506","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s40261-019-00762-z","article-title":"Benefits of beta-blockade in sepsis and septic shock: A systematic review.","volume":"39","author":"Lee","year":"2019","journal-title":"Clin Drug Investig"},{"key":"R21-20250506","first-page":"ED000142","article-title":"Updated guidance for trusted systematic reviews: A new edition of the Cochrane Handbook for Systematic Reviews of Interventions.","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R22-20250506","doi-asserted-by":"crossref","first-page":"E901","DOI":"10.1503\/cmaj.200077","article-title":"Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses.","volume":"192","author":"Schandelmaier","year":"2020","journal-title":"CMAJ"},{"key":"R23-20250506","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jclinepi.2022.07.014","article-title":"GRADE guidance 34: Update on rating imprecision using a minimally contextualized approach.","volume":"150","author":"Zeng","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"R24-20250506","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jclinepi.2019.10.014","article-title":"GRADE guidelines 26: Informative statements to communicate the findings of systematic reviews of interventions.","volume":"119","author":"Santesso","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"R25-20250506","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S2213-2600(20)30037-0","article-title":"Efficacy and safety of landiolol, an ultra-short-acting \u03b21-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): A multicentre, open-label, randomised controlled trial.","volume":"8","author":"Kakihana","year":"2020","journal-title":"Lancet Respir Med"},{"key":"R26-20250506","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.2023.20134","article-title":"Landiolol and organ failure in patients with septic shock: The STRESS-L randomized clinical trial.","volume":"330","author":"Whitehouse","year":"2023","journal-title":"JAMA"},{"key":"R27-20250506","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-018-3024-6","article-title":"Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): Study protocol for a randomized controlled trial.","volume":"19","author":"Unger","year":"2018","journal-title":"Trials"},{"key":"R28-20250506","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021.","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"key":"R29-20250506","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jointm.2022.01.004","article-title":"Beta-blockers in septic shock: What is new?","volume":"2","author":"Lescroart","year":"2022","journal-title":"J Intensive Med"},{"key":"R30-20250506","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/MOL.0000000000000870","article-title":"Circulating protein and lipid markers of early sepsis diagnosis and prognosis: A scoping review.","volume":"34","author":"Barber","year":"2023","journal-title":"Curr Opin Lipidol"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006604","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T10:00:35Z","timestamp":1746525635000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000006604","relation":{},"ISSN":["0090-3493","1530-0293"],"issn-type":[{"value":"0090-3493","type":"print"},{"value":"1530-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]}}}